packageDeucravacitinib

deucravacitinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Deucravacitinib is a kinase inhibitor used to treat psoriasis. It is authorised in the European Union for this condition.

Summary written by glm-5.3-flash from Wikidata Q113940477 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:deucravacitinib
ATC codes:L04AF07
DrugBank:DB16650
PubChem CID:134821691
Wikidata:Q113940477
formula:C20H22N8O3
molar mass:422.449 g/mol (PubChem CID 134821691)
logP:1.2 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown